v3.26.1
Condensed Statement of Changes in Shareholders’ Deficit (Unaudited) - 3 months ended Mar. 31, 2026 - USD ($)
Ordinary Shares
Class A
Ordinary Shares
Class B
 [1]
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2025 $ 958 $ 24,042 $ (58,073) $ (33,073)
Balance (in Shares) at Dec. 31, 2025 9,583,333      
Accretion for Class A ordinary shares to redemption amount (9,947,343) (10,959,375) (20,906,718)
Sale of private placement Units $ 76 7,599,924 7,600,000
Sale of private placement Units (in Shares) 760,000        
Fair value of public warrants at issuance 2,479,688 2,479,688
Allocated value of transaction costs to Class A shares (156,311) (156,311)
Net income 1,886,022 1,886,022
Balance at Mar. 31, 2026 $ 76 $ 958 $ (9,131,426) $ (9,130,392)
Balance (in Shares) at Mar. 31, 2026 760,000 9,583,333      
[1] As of December 31, 2025, includes an aggregate of up to 1,250,000 Class B ordinary shares that were subject to forfeiture by the holders thereof depending on the extent to which the underwriters’ over-allotment option was exercised (Note 5). On January 12, 2026, the Company consummated its Initial Public Offering and sold 28,750,000 Units, including 3,750,000 Units sold pursuant to the full exercise of the underwriters’ over-allotment option; hence, the 1,250,000 Class B ordinary shares are no longer subject to forfeiture.